Hunan Jiudian Pharmaceutical Co Ltd Relative Valuation - Hunan Jiudian Pharmaceutical Co Ltd - Alpha Spread

Hunan Jiudian Pharmaceutical Co Ltd
SZSE:300705

Watchlist Manager
Hunan Jiudian Pharmaceutical Co Ltd Logo
Hunan Jiudian Pharmaceutical Co Ltd
SZSE:300705
Watchlist
Price: 24.63 CNY 13.45% Market Closed
Market Cap: 12B CNY
Have any thoughts about
Hunan Jiudian Pharmaceutical Co Ltd?
Write Note

Relative Value

The Relative Value of one Hunan Jiudian Pharmaceutical Co Ltd stock under the Base Case scenario is 41.15 CNY. Compared to the current market price of 24.63 CNY, Hunan Jiudian Pharmaceutical Co Ltd is Undervalued by 40%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
41.15 CNY
Undervaluation 40%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
33
vs Industry
27
Median 3Y
4.1
Median 5Y
4.1
Industry
2.6
Forward
3.7
vs History
88
vs Industry
14
Median 3Y
31.6
Median 5Y
34.5
Industry
22.9
Forward
24.2
vs History
87
vs Industry
19
Median 3Y
31.8
Median 5Y
29.6
Industry
17.6
vs History
1
vs Industry
10
Median 3Y
77.1
Median 5Y
74.5
Industry
25.2
vs History
46
vs Industry
10
Median 3Y
6
Median 5Y
5.5
Industry
2.2
vs History
38
vs Industry
25
Median 3Y
4.1
Median 5Y
4
Industry
2.7
Forward
3.7
vs History
34
vs Industry
33
Median 3Y
5.3
Median 5Y
5.3
Industry
5.4
vs History
87
vs Industry
12
Median 3Y
27.7
Median 5Y
29.1
Industry
13.9
Forward
16.9
vs History
87
vs Industry
15
Median 3Y
27.7
Median 5Y
29.1
Industry
17.3
Forward
20.5
vs History
87
vs Industry
20
Median 3Y
31.3
Median 5Y
29.3
Industry
16.1
vs History
53
vs Industry
6
Median 3Y
45.8
Median 5Y
45.4
Industry
18.8
vs History
36
vs Industry
15
Median 3Y
5.2
Median 5Y
4.9
Industry
2

Multiples Across Competitors

Competitors Multiples
Hunan Jiudian Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Hunan Jiudian Pharmaceutical Co Ltd
SZSE:300705
12B CNY 4.2 26.4 23 23
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
843.2B USD 21.7 114.8 57.4 64.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.5T DKK 13.5 38.8 25.9 29.7
US
Johnson & Johnson
NYSE:JNJ
385.8B USD 4.5 10.1 12.4 16.1
US
Merck & Co Inc
NYSE:MRK
278.3B USD 4.5 20.3 13.7 16.8
UK
AstraZeneca PLC
NASDAQ:AZN
240.2B USD 4.9 37.3 17.1 25.6
CH
Roche Holding AG
SIX:ROG
205.6B CHF 3.5 17.9 10.1 11.9
CH
Novartis AG
SIX:NOVN
190.6B CHF 4.5 13.7 10.8 16.1
US
Pfizer Inc
NYSE:PFE
162B USD 2.9 -62.4 12.6 20.4
P/E Multiple
Earnings Growth
CN
Hunan Jiudian Pharmaceutical Co Ltd
SZSE:300705
Average P/E: 34.9
26.4
128%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
114.8
425%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
38.8
90%
US
Johnson & Johnson
NYSE:JNJ
10.1
-22%
US
Merck & Co Inc
NYSE:MRK
20.3
7 419%
UK
A
AstraZeneca PLC
NASDAQ:AZN
37.3
175%
CH
Roche Holding AG
SIX:ROG
17.9
30%
CH
Novartis AG
SIX:NOVN
13.7
19%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -62.4
712%

See Also

Discover More
Back to Top